Oral candidiasis
Variable POR 95% CI c2 p
Gender        
      Female 1 - - -
      Male 0.3 0.05-1.76 1.92 0.19
Use of antimicrobials        
       Yes 1 - - -
       No 1.11 1.03-1.18 0.54 0.6
Susceptibility        
      Intermediate 1 - - -
      Sensitive 0.14 0.02-0.74 6.7 0.03
CD4 lymphocytes        
      <50 1 - - -
      51-100 5.9 0.91-38.25 4.32 0.09
Time since HIV diagnosis        
      <1 month 1 - - -
      >1 month 5.92 0.91-38.25 4.32 0.09
Age group (years)
      17-29 1 - - -
     30-39 1.12 0.19-6.60 0.89 0.63
     40-49 1.43 0.18-11.2 0.72 0.56
     ≥50 1.64 0.12-20.9 0.7 0.57
Esophageal candidiasis
Gender        
      Female 1 - - -
      Male 1.18 0.22-6.1 0.04 0.6
Use of antimicrobials        
     Yes 1 - - -
     No 1.35 0.14-12.7 0.7 0.63
Susceptibility        
     Intermediate 1 - - -
     Sensitive 0.06 0.01-0.36 14.7 0.001
CD4 lymphocytes        
     <50 1 - - -
     51-100 0.73 0.64-0.83 2.13 0.16
Time since HIV diagnosis        
     <1 month 1 - - -
     >1 month 1.54 0.26-9.02 0.23 0.46
Age groups (years)        
     17-29 1 - - -
     30-39 1.62 0.50-5.25 0.41 0.3
     40-49 1.14 0.25-5.02 0.85 0.57
     ≥ 50 1.33 0.20-8.70 0.76 0.55
POR, prevalence odds ratio.        
Table 3: Bivariate analysis of the risk factors for oral and esophageal candidiasis.
Goto home»